Savolitinib, AstraZeneca Complete Enrolment for Phase II Clinical Trial in Papillary Renal Cell Carcinoma
October 13, 2015 at 04:31 AM EDT
Hutchison China MediTech Limited (OTC: HNCMF) today announces that Hutchison MediPharma Limited, its drug R&D subsidiary, and ...